<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>3</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2008</Year>
        <Month>07</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Coronary Artery Bypass Surgery versus Medical Treatment in Patients with Low Ejection Fraction and Coronary Artery Disease</title>
    <FirstPage>145</FirstPage>
    <LastPage>150</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hakimeh</FirstName>
        <LastName>Sadeghian</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Salarifar</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas Ali</FirstName>
        <LastName>Karimi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrab</FirstName>
        <LastName>Marzban</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kyomars</FirstName>
        <LastName>Abbasi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoumeh</FirstName>
        <LastName>Lotfi-Tokaldany</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmood</FirstName>
        <LastName>Sheikhfathollahi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Majd</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sirous</FirstName>
        <LastName>Jahangiri</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Hesameddin</FirstName>
        <LastName>Abbasi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: We compared the outcomes in patients with a low ejection fraction (EF) and multivessel coronary artery disease (CAD) who either underwent coronary artery bypass grafting (CABG) or received medical treatment (MT) after a viability study via dobutamine stress echocardiography (DSE).

Methods: We considered patients with CAD and left ventricular ejection fraction (LVEF) &lt;40% who were referred for DSE, and enrolled 106 patients (89% male, mean age: 55.8&#xB1;9.7 years) with &#x2265;4 viable segments. According to DSE, all the 106 patients were suitable for revascularization. We compared the outcomes between the patients who underwent CABG and those who received MT at a mean follow-up time of 8 months. 

Results: Both groups had similar baseline characteristics and rest EF. Thirty-three (31.1%) patients underwent CABG and 73 (68.9%) received MT. There was no significant difference between the CABG and MT groups in terms of mortality rate (9.1% vs. 11.0 %) and improvement in New York Heart Association functional class at follow-up. In the CABG group, patients with LVEF &#x2264;25% had higher mortality compared to patients with LVEF &gt;25% (100% vs. 40%, P&lt; 0.05).

Conclusion: The patients with CAD and a low EF had the same survival rate after both CABG and MT at mid-term follow-up. Long-term follow-up is needed to show the survival benefit of CABG in such patients with an acceptable extent of viable myocardium.&#xA0;</abstract>
    <web_url>https://rhythm.tums.ac.ir/index.php/jthc/article/view/96</web_url>
    <pdf_url>https://rhythm.tums.ac.ir/index.php/jthc/article/download/96/94</pdf_url>
  </Article>
</Articles>
